MDxHealth holder plans sale of 1.5M shares

A 10% stockholder of MDxHealth SA has filed to sell up to 1.5 million NASDAQ-listed common shares through a registered public offering for cash.

Available on EDGAR 09/17/2026 - 05:43 PM EDT Accepted by SEC EDGAR 09/17/2026 - 05:42 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MDxHealth SA (MDXH) received a notice under Rule 144 that a 10% stockholder, identified as Bleichroeder, plans to sell up to 1,500,000 shares of common stock. The shares are to be sold for cash through a registered public offering, with BTIG LLC as broker and the stock listed on NASDAQ.

Key Figures

Shares to be sold: 1,500,000 shares Aggregate market value: $1,056,900.00 Planned sale date: September 26, 2024 +2 more

5 metrics

Shares to be sold 1,500,000 shares Maximum number of MDxHealth SA common shares covered by the Form 144 notice

Aggregate market value $1,056,900.00 Value listed for 1,500,000 common shares in the securities information section

Planned sale date September 26, 2024 Date associated with the registered public offering of 1,500,000 shares

Ownership stake classification 10% stockholder Status of Bleichroeder, the person for whose account the securities are to be sold

Listing venue NASDAQ Exchange on which the common stock referenced in the notice is listed

Key Terms

Rule 144, registered public offering, 10% Stockholder, Common Stock

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

registered public offering financial

"Common Stock | 09/26/2024 | Registered Public Offering | Issuer"

A registered public offering is when a company files required documents with regulators to sell new shares or bonds to the general public, providing standardized financial and business information for transparency. For investors, it matters because it creates an opportunity to buy newly issued securities while often increasing market liquidity, but it can also dilute existing ownership and affect share price as supply and company funding needs change—think of a bakery baking extra loaves that can satisfy more customers but slightly reduces each owner's slice of the original batch.

10% Stockholder financial

"In addition, information shall be given as to sales by all persons... 10% Stockholder"

Common Stock financial

"Common Stock | BTIG LLC 350 Bush St, 9th FL, San Francisco CA 94104"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing reveal about MDXH shares?

The filing states that a 10% stockholder plans to sell up to 1,500,000 shares of MDxHealth SA common stock for cash through a registered public offering, with BTIG LLC as the broker and the shares listed on NASDAQ.

How many MDXH shares are covered by this Form 144 notice?

The notice covers up to 1,500,000 shares of MDxHealth SA common stock. This amount appears both in the securities information section and in the section describing the securities to be sold.

What is the indicated market value of the MDXH shares in the Form 144?

The securities information section lists 1,500,000 shares of common stock with an aggregate market value of approximately $1,056,900.00, tied to the NASDAQ-listed security described in the filing.

Who is selling MDXH shares according to the Form 144?

The seller is identified as Bleichroeder, described as a 10% stockholder. The filing notes that information must cover that person and others whose sales must be aggregated under paragraph (e) of Rule 144.

How will the MDXH shares be sold under this Form 144?

The Form 144 describes a registered public offering for cash as the method of sale. BTIG LLC is listed as the broker for the common stock to be sold on NASDAQ.

What dates are associated with the planned MDXH share sale?

The securities to be sold section lists September 26, 2024 as the date related to the registered public offering of 1,500,000 shares. Another date, September 17, 2026, appears in the securities information and signature areas.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001781002
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MDxHealth SA
SEC File Number	001-40996
Address of Issuer	CAP BUSINESS CENTER RUE D'ABHOOZ, 31, B-4040 HERSTAL BELGIUM 00000
Phone	949-271-9221
Name of Person for Whose Account the Securities are To Be Sold	Bleichroeder LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	BTIG LLC 350 Bush St, 9th FL, San Francisco CA 94104	1500000	1056900.00	95417382	09/17/2026	NASDAQ CM

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/26/2024	Registered Public Offering	Issuer			1500000	09/26/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Andrew Gundlach
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)